Application Software

Xanadu Quantum Tech - B

Xanadu Quantum Technologies Secures Up to $300 Million Equity Financing Agreement

Northland and Canaccord Reiterate Buy Rating on Xanadu Quantum Technologies with Targets of $43-$45

Xanadu Q1 Loss per Share $0.28, Revenue Rises to $2.8 Million

Xanadu Announces Q1 2026 Financial Results and Emphasizes Long-Term Quantum Computing Strategy

Xanadu Quantum Tech - B to Release FY2026 Q1 Earnings on May 14 After-Market (EST), Forecast Revenue USD 1.43 M

Xanadu Quantum Technologies Limited Sees Significant Growth in Call Option Trades

Xanadu Quantum Tech - B released FY2025 earnings on April 9 (EST), actual revenue USD 4.617 M, actual EPS USD -14.2911

Xanadu Quantum Tech - B released FY2025 Q4 earnings on April 9 (EST), actual revenue USD 1.875 M, actual EPS USD -4.6457

Xanadu Quantum Tech - B released FY2023 earnings on March 2, 2026 (EST), actual revenue USD 2.479 M, actual EPS USD -7.2743

Xanadu Quantum Tech - B released FY2025 9 Months Earnings on March 2, 2026 (EST), Actual Revenue: USD 2.922 M, Actual EPS: USD -9.934

Xanadu Quantum Tech - B released FY2024 9 Months Earnings on March 2, 2026 (EST), with actual revenue of USD 941K and EPS of USD -7.267

Xanadu Quantum Tech - B released FY2025 Q3 earnings on March 2, 2026 (EST), actual revenue USD 987 K, actual EPS USD -4.1029

Xanadu Quantum Tech - B released FY2024 Q4 earnings on March 2, 2026 (EST) with actual revenue of USD 711K and EPS of USD -2.201

Xanadu Quantum Tech - B released FY2024 Q3 earnings on March 2, 2026 (EST), actual revenue USD 482K, actual EPS USD -2.1236

Xanadu Quantum Tech - B released FY2024 earnings on March 2, 2026 (EST) with actual revenue of USD 1.589 M and EPS of USD -9.3481

Xanadu Quantum Tech - B released FY2025 Q1 earnings on November 21, 2025 (EST), actual revenue USD 877.5 K, actual EPS USD -2.7688

Xanadu Quantum Tech - B released FY2025 Semi-Annual earnings on November 21, 2025 (EST), actual revenue USD 1.755 M, actual EPS USD -5.5376

Xanadu Quantum Tech - B released FY2025 Q2 earnings on November 21 (EST), actual revenue USD 1.057M, actual EPS USD -3.0622

Xanadu Quantum Tech - B released FY2024 Q2 earnings on November 21, 2025 (EST), with actual revenue of USD 261K and EPS of USD -2.6316

Xanadu Quantum Tech - B released FY2024 Semi-Annual earnings on November 21, 2025 (EST), actual revenue USD 396K, actual EPS USD -5.0235

Akari Therap

PicoCELA

rYojbaba

QTREX Quantum

Baiya

Leifras

VCI Global

CO2 ENERGY TRANSITION CORP. COM USD0.0001 15/10/2028 (SUB/RIGHTS)

Tradr 2X Long RGTI Daily ETF

Hyliion

QBTS

D-Wave Quantum secured a proposed $100 million funding commitment under the U.S. CHIPS Act to enhance its quantum computing technologies. The stock rose 21.76% to $23.50 following the announcement. Despite a first-quarter loss of 5 cents per share, the company reported significant growth in bookings. Analysts maintain a Buy rating with a price target averaging $38.00, indicating potential for further upward movement in stock price.

benzinga_article

D-Wave Quantum

D-WAVE QUANTUM INC C/WTS 05/08/2027 (TO PUR COM)

What's Going On With D-Wave Stock On Thursday?

XNDU

ADIL

Xanadu Quantum Tech - B pre-market up 8.65%; Adial Pharmaceuticals pre-market down 7.07%; Wheeler Real Estate pre-market up 99.64%; PicoCELA pre-market up 76.39%; Agape ATP pre-market up 59.81%

Price Alert

Adial Pharmaceuticals

Wheeler Real Estate

Agape ATP

Pre-market hot trades in US stocks: Xanadu Quantum Tech - B up 8.65% in pre-market; Adial Pharmaceuticals down 7.07% in pre-market

Xanadu Quantum Technologies Limited has announced a synthetic at-the-market equity facility for up to $300 million with Yorkville Advisors. The funds will be used for working capital and corporate purposes. The program allows Xanadu to issue Class B shares over three years, with proceeds aimed at supporting its growth strategy in quantum computing. A registration statement will be filed with the SEC for share resale qualification.

StockTitan

Xanadu Announces $300 Million Synthetic At-The-Market Program | XNDU Stock News

IMVT

NVTS

ALAB

FCEL

HIVE

KURA

Immunovant(IMVT) rose 35.26%, with a trading turnover 669.9 Million USD, and a year-to-date rose 39.9%. T1 Energy(TE) rose 26.45%, with a trading turnover 910.4 Million USD, and a year-to-date rose 30.2%. Xanadu Quantum Tech - B(XNDU) rose 20.56%, with a trading turnover 110.8 Million USD, and a year-to-date rose 31.2%.

Top Gainers&Losers

Immunovant

T1 Energy

Navitas Semiconductor

Sellas Life Sciences

Astera Labs

Guardant Health

FuelCell Energy

HIVE Digital Tech

Kura Oncology

Top 10 US Stock Gainers (5.20)

Xanadu Quantum Technologies Ltd (NASDAQ:XNDU) shares surged 22.95% to $14.42 as traders returned to high-beta tech amid a broader market rally. Despite this rebound, the stock remains 30.8% below its 20-day SMA, indicating ongoing chart damage. Key support is at $12, with a break below this level risking a drop towards its 52-week low of $6.97. Xanadu focuses on photonic devices and quantum computing, making it sensitive to market sentiment shifts.

Xanadu Stock Is Moving Today: Here's What The Chart Is Signaling

Xanadu Quantum Tech - B rose 18.34%; Palantir Tech rose 0.75%, with a trading volume of USD 1.726 billion; IREN rose 7.17%, with a trading volume of USD 838 million; S&P 500 fell 1.13%, with a trading volume of USD 738 million; SAP fell 0.35%, with a market value of USD 207.9 billion

Palantir Tech

IREN

Salesforce

SAP AG-Sponsored

U.S. stock market midday update: Xanadu Quantum Tech up 18.34%, clear capital flow, market sentiment triggers volatility attention

Xanadu Quantum Technologies Inc. (XNDU) reported a fourfold revenue increase to $2.8 million in Q1, but also widened its net loss to $20.6 million. Despite solid growth and a strong cash base, the stock dropped about 10% as the company is still in a costly build phase. Analysts, however, see potential for significant upside.

Tip Ranks

Xanadu Stock Drops after Q1 Earnings, but Analysts See Big Upside for XNDU

Xanadu’s latest earnings show that quantum computing is often a high-stakes waiting game.

Xanadu Quantum revenue increases fourfold. Why the stock is falling.

Xanadu Quantum Tech - B(XNDU.US)